Medication info
Bonviva Plus Tablet

Bonviva Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tabletCholecalciferol Concentrate Powder›240mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
White to almost white rectangular film-coated tablet
Packaging
1 tablet/PTP
Approval status
Active

MFDS item code 201308067 · Approved 2013.07.08 · Insurance code 652604790

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium) : - This medicine should be swallowed with plenty of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take the medicine on the regularly scheduled dosing day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the originally scheduled dosing day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled dosing day, and thereafter take 1 tablet each month on the originally scheduled dosing day. - Do not take 2 tablets within the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. This medicine provides a month's supply of vitamin D at 800IU per day when taken once a month. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dose adjustment is necessary.
Child dose
Efficacy and safety in children 18 years of age or younger have not been studied.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis occurring in postmenopausal women. Osteoporosis is a condition characterized by low bone density, making bones weak and easily fractured. This drug helps to increase bone strength and reduce fracture risk. It is particularly effective for maintaining and enhancing bone health in postmenopausal women. Therefore, it is used for the prevention and treatment of osteoporosis.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium) : - This medicine should be swallowed with plenty of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take the medicine on the regularly scheduled dosing day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the originally scheduled dosing day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled dosing day, and thereafter take 1 tablet each month on the originally scheduled dosing day. - Do not take 2 tablets within the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. This medicine provides a month's supply of vitamin D at 800IU per day when taken once a month. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dose adjustment is necessary.

Child dose

Efficacy and safety in children 18 years of age or younger have not been studied.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to this medication or any of its components, patients with untreated hypocalcemia, patients who cannot sit or stand upright for at least 60 minutes, patients with esophageal problems that impede the passage of food, and patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. Patients with severe renal impairment should exercise particular caution when using this medication. If renal function is significantly impaired, the administration of this medication should be carefully considered. Various side effects can occur when taking this medication. The most common side effects include dyspepsia, constipation, nausea, abdominal pain, diarrhea, headache, dizziness, muscle pain, joint pain, and influenza-like symptoms. Rarely, symptoms such as skin rash, angioedema, facial swelling, chest discomfort, and difficulty breathing have also been reported. Additionally, this medication can cause serious esophageal issues, such as esophagitis, esophageal ulcers, and esophageal strictures. Therefore, it is essential to take it according to the doctor's instructions and ensure proper administration. If difficulty swallowing, chest pain, or pain upon swallowing occurs, immediately stop taking the medication and consult medical personnel. It is important to adequately intake calcium and vitamin D while taking this medication. In particular, if taking calcium supplements or antacids, it is advisable to space their intake at least 1 hour apart as they may hinder the absorption of this medication. As a bisphosphonate, there is a risk of severe osteonecrosis of the jaw, so it is advised that particularly cancer patients or patients requiring dental treatment undergo oral examinations before taking it, and avoid excessive dental procedures during treatment. Pregnant or breastfeeding women are advised not to use this medication, and safety and efficacy in children and adolescents under 18 years have not been established. In case of overdose, gastrointestinal disturbances or hypocalcemia may occur, so adherence to the prescribed dosage is crucial, and if any unusual symptoms arise, consult medical personnel immediately. Finally, this medication should be kept out of the reach of children, and unused medications should be disposed of properly to prevent environmental pollution.

Side effects

Indigestion, constipation, upper abdominal pain, nausea, abdominal pain, diarrhea, headache, dizziness, pain, chills, influenza-like illness, chest discomfort, facial swelling, muscle pain, bone pain, back pain, nasopharyngitis, dyspnea, rash, dry mouth, ptosis, frequent urination, cystitis, dysuria, leg pain, generalized edema, syncope, shingles, unspecified injuries, unspecified abrasions, dysphagia, vomiting, gastritis, esophageal ulcer, esophagitis, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial edema, hives, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, asthma exacerbation, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical subtrochanteric fracture, subtrochanteric femoral fracture, abnormal sensation in the eye, weakness, pruritus, loss of appetite, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, gastroesophageal reflux disease, esophageal erosion, vascular disease, pneumonia, pyelonephritis, ovarian cyst, cervical cancer, vomiting, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

White to almost white rectangular film-coated tablet

Package unit

1 tablet/PTP

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.